Objective sleep duration and response to combined pharmacotherapy and cognitive behavioral insomnia therapy among patients with comorbid depression and insomnia: a report from the TRIAD study is a research paper published in Journal of Clinical Sleep Medicine (2023). On theSindex it has a DataRank of 0.521. It has been cited 12 times, with 11 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.385
From this paper's citation signal
Citation Network Contribution
0.136
From 7 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 11 citers.
NHLBI NIH HHS
Grant: R01 HL096492
NIMH NIH HHS
Grant: R01 MH078961
NIMH NIH HHS
Grant: R01 MH079256
NIMH NIH HHS
Grant: R01 MH078924
National Institutes of Health
Grant: 5R01MH078924-03
1/3-Improving Depression Outcome by Adding CBT for Insomnia to Antidepressants
National Institutes of Health
Grant: 5R01MH078961-03
2/3-Improving Depression Outcome by Adding CBT for Insomnia to Antidepressants
National Institutes of Health
Grant: 5R01MH079256-03
3/3-Improving Depression Outcome by Adding CBT for Insomnia to Antidepressants
National Institutes of Health
Grant: 5R01HL096492-03
Biomarkers of the Response to CBT for Insomnia in Major Depression
FWCI
2.41
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals